Clinical trials
Completed Phase 1 Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,384 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 13 |
| 2001 | 20 |
| 2002 | 9 |
| 2003 | 36 |
| 2004 | 54 |
| 2005 | 53 |
| 2006 | 77 |
| 2007 | 97 |
| 2008 | 88 |
| 2009 | 85 |
| 2010 | 85 |
| 2011 | 99 |
| 2012 | 85 |
| 2013 | 81 |
| 2014 | 69 |
| 2015 | 74 |
| 2016 | 66 |
| 2017 | 48 |
| 2018 | 49 |
| 2019 | 33 |
| 2020 | 41 |
| 2021 | 30 |
| 2022 | 22 |
| 2023 | 20 |
| 2024 | 5 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,384 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 71 |
| GlaxoSmithKline | 54 |
| Boehringer Ingelheim | 53 |
| AstraZeneca | 46 |
| Bayer | 46 |
| Eli Lilly and Company | 41 |
| Novartis Pharmaceuticals | 35 |
| Bristol-Myers Squibb | 32 |
| Hoffmann-La Roche | 32 |
| Merck Sharp & Dohme LLC | 32 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 1,384 |
| Neoplasm Metastasis | 133 |
| Carcinoma, Non-Small-Cell Lung | 102 |
| Breast Neoplasms | 85 |
| Lymphoma | 75 |
| Melanoma | 65 |
| Prostatic Neoplasms | 55 |
| Colorectal Neoplasms | 53 |
| Lung Neoplasms | 52 |
| Ovarian Neoplasms | 52 |
Trials
Showing 1 to 25 of 1,384. Each trial links to its page on Pharma Observatory.
1,284 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.